I have empathy for you since I understand your pain from the "other" stock but CYDY is not like that one. This is a very real situation and my investment will go long term soon. I am here for the final bell...meaning a buyout. In the interim I have not seen one pump and dump scenario play out. I know there has been dilution here as they need funding but if you bought below $1.00 you bought cheaper than me and congrats on that. Payday will be a 10 bagger minimum imo but don't expect it overnight. There are people here with hundreds of thousand$ invested here and some of them are doctors so this is not your typical pump and dump situation. GLTY.
Lol Energy. Need to break this out over a buck and make good on timelines that de-risk Pro-140. Hanging under a buck is like an endless hangover.
Execution is the juice needed here. Adjunct enrollment completed and Mono Trial1st patient injected are at the top of the list. Should likely get Mono news before 2017. Bottom line is Pro-140 will not be taken seriously by BP or institutions until approval appears to be a given. There is No question as to the efficacy and safety of Pro-140. Regardless the FDA is the gatekeeper that decides how many hoops to jump through and they seem to be supportive. 2017 will answer those questions. Not that long to wait after being in for nearly four years.
Emergcy- Thank you for posting (venting). This is not pump and dump in no way. The results as Charlie has said for 1 year speak for volumes for pro 140. I think the killer here was the FDA because they didn't have protocol or guidance established but only from Haart. A big delay but positive looking back. I believe their last sit down with FDA has overcome it and we should be pushed up from here. Partnership or buy out for a portion of the company (HIV) could be huge and cheap for any BP. Please refer to the seeking alpha article that says Gilead, the leader in HIV pills is not planning to spend more on R&D but look at new strategic partners/acquisitions that are game changers to HAART. CYDY as the most visible. It's been a long road to here but no HIV company has progressed as quickly through FDA as CYDY and it should pick up from here. Not pumping but expressing a stock north of $8 easily soon. Keep posting. Your input is welcomed. Chump
News 
Market Data 
Discover 
AI
